Status:
UNKNOWN
Effect of Adding TTPB to SAPB in Breast Cancer Surgery
Lead Sponsor:
Bezmialem Vakif University
Conditions:
Acute Pain
Opioid Use
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Breast cancer is the most common malignancy in women worldwide. Even minor breast surgery can cause significant postoperative pain (PP). PP can turn into chronic pain in 25-40% of cases. Inadequate PP...
Eligibility Criteria
Inclusion
- ASA I-II-III
- BMI 20 to 35 kg / m2
- Patients scheduled for breast cancer surgery procedure
Exclusion
- Patients with previously known allergies to the drugs to be used in the study,
- Infection near the puncture site,
- Patients with previous symptoms of neurological disease (TIA, syncope, dementia, etc.)
- Known coagulation disorders,
- Alcohol and drug use,
- Disorder of consciousness,
- Opioid use equal to or greater than 60 mg oral morphine equivalent per day,
- Patients with pre-existing neuropathic pain,
- Liver failure, renal failure, cardiac failure
- Morbid obesity (body mass index \[BMI\] \> 35 kg m-2)
- Uncontrolled diabetes mellitus
- Women during pregnancy or breastfeeding
- Not approving the informed consent form
Key Trial Info
Start Date :
July 12 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06082141
Start Date
July 12 2023
End Date
June 1 2024
Last Update
November 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aylin Ceren Şanlı
Istanbul, Turkey (Türkiye)